Abstract Objectives: To investigate recorded poor insight in relation to mental health and service use outcomes in a cohort with…
Abstract Background: Novel Psychoactive Substances (NPS) are a heterogeneous class of synthetic molecules including synthetic cannabinoid receptor agonists (SCRAs). Psychosis…
Abstract A substantial body of credible evidence has accumulated that suggest that cannabis use is an important potentially preventable risk…
Abstract Background: Cannabis and tobacco have contrasting cognitive effects. Smoking cannabis with tobacco is prevalent in many countries and although…
Abstract Background: Around 35–45 % of people in contact with services for a first episode of psychosis are using cannabis.…
Abstract Background: Cannabis is a widely used drug associated with increased risk for psychosis. The dopamine hypothesis of psychosis postulates…
Abstract Background: This study aimed to evaluate synthetic cannabinoid (SC)-induced psychosis in terms of patient profile and clinical characteristics with…
Abstract Introduction: There is growing evidence for natural recovery from cannabis use by people with psychosis, but mechanisms underpinning it…
Abstract In 2007, we proposed an explanation of delusion formation as aberrant prediction error-driven associative learning. Further, we argued that…
Abstract There is a high prevalence of cannabis use reported in non-affective psychosis. Early prospective longitudinal studies conclude that cannabis…